A detailed history of Ameritas Investment Partners, Inc. transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 585 shares of GLSI stock, worth $7,248. This represents 0.0% of its overall portfolio holdings.

Number of Shares
585
Previous 585 -0.0%
Holding current value
$7,248
Previous $10,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$12.07 - $19.04 $7,060 - $11,138
585 New
585 $10,000
Q2 2022

Aug 12, 2022

SELL
$7.14 - $20.36 $2,256 - $6,433
-316 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$31.24 - $53.6 $9,871 - $16,937
316 New
316 $14,000

Others Institutions Holding GLSI

About Greenwich LifeSciences, Inc.


  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $159M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.